Kamada (KMDA) Non-Current Deferred Tax Liability (2018 - 2026)
Kamada's (KMDA) quarterly Non-Current Deferred Tax Liability came in at $2.9 million in Q1 2026, up 39.06% YoY from $2.1 million in Q1 2025, and up 73.59% on a QoQ basis from $1.7 million in Q4 2025.
Kamada (KMDA) Non-Current Deferred Tax Liability (2018 - 2026) Analysis & Trends
Kamada (KMDA) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $2.9 million in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability rose 39.06% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (up 39.06% YoY) and the FY2025 annual result came in at $1.7 million, up 238.32% from the prior year.
- Non-Current Deferred Tax Liability climbed to $2.9 million in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $2.9 million in Q1 2026 to a low of $488000.0 in Q4 2024.
- A 3-year average of $1.6 million and a median of $1.7 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2025 — Non-Current Deferred Tax Liability jumped 238.32% — and 2026, when it jumped 39.06%.
- Tracing KMDA's Non-Current Deferred Tax Liability over 3 years: stood at $488000.0 in 2024, then jumped by 238.32% to $1.7 million in 2025, then jumped by 73.59% to $2.9 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $2.9 million (Q1 2026), $1.7 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Kamada | 464.34 Mn | 434.87 Mn | 22.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.82 Mn |
| Jun 30, 2026 | 3.82 Mn |
| Mar 31, 2026 | 2.87 Mn |
| Mar 31, 2026 | 2.87 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 659,000.00 |
| Jun 30, 2025 | 659,000.00 |
| Mar 31, 2025 | 2.06 Mn |
| Mar 31, 2025 | 2.06 Mn |
| Dec 31, 2024 | 488,000.00 |
| Dec 31, 2024 | 488,000.00 |
| Sep 30, 2020 | 298,000.00 |
| Sep 30, 2020 | 298,000.00 |
| Jun 30, 2020 | 632,000.00 |
| Jun 30, 2020 | 632,000.00 |
| Mar 31, 2020 | 939,000.00 |
| Mar 31, 2020 | 939,000.00 |